Egyptian Association of Vascular Biology and Research ( EAVA)


Prof Dr Ashraf Reda

DOB: 7-11-1955

Curent positions:

  • of cardiology department, College of medicine, Menofiya University.
  • President of EAVA (Egyptian Association of Vascular biology and Atherosclerosis )
  • Director and PI of the ongoing Egyptian Cardiovascular Risk Factors Project
  • National Lead Investigator for Egypt in FHSC of European Atherosclerosis Society
  • Founder of WGLVR (Working Group for Lipidology, Vascular biology and Research),

a division of the Egyptian Society of Cardiology

  • Founding Chairman of EGYBAC (Egyptian board of Accreditation in Cardiology)
  • Former Elect board member and Treasure EgSC

Qualifications:

  • BCH: Ain Shams University, December 1979.
  • Master degree in cardiology. El-Azhar University, 1984.
  • MD degree in cardiology. Menofiya University, 1991.
  • FESC, fellowship of European Society of Cardiology

Official Career:

  • 1981-1984: Acting Cardiology Resident: ElAzhar University
  • 1985-1990: Assistant lecturer of Cardiology: ElAzhar University
  • 1990-1992: Assistant lecturer of Cardiology: Menofia University
  • 1992-1997: Lecturer of Cardiovascular Medicine
  • 1997-2000: Ass. Professor of Cardiovascular Medicine & acting head of Cardiology department, Menofia University.
  • 28-1-2002: Professor of Cardiology
  • 28-1-2002-10-12-2005: Head of Cardiology department
  • 11-12-2005- 11-12-2008: Vice Dean for Postgraduate studies, Research and Cultural affair: College of Medicine, Menofiya university
  • 14/12/2008-15/1/2015 Head of cardiology department Menofia University.

Clinical Experiences:

  • One year Internship: Ain Shams University hospital.
  • Three years Cardiology resident: El-Azhar University.
  • Five year CCU specialist As-Salam international hospital
  • Clinical and invasive consultant cardiology, As-Salam hospital since 1991.
  • Visiting clinical and interventional cardiology consultant Hamad medical corporation, Doha, Qatar, 1991-1993.
  • Director of cardiac catheterization lab. And CCU, Menofia university, 1991-2006.
  • Head of cardiology Dep. Menofia University-Egypt 2002-2005 and 2008 -2015

Medico-social activities:

  • Chairman of the Annual Lipid conference and interactive cardiology course since 1997 „Annual Cardio-lipid congress”
  • President of EAVA
  • Chairman of The 31th annual international congress of the Egyptian Society of cardiology (EGSC) 2004
  • Elective board member of the Egyptian society of Cardiology since 2005.
  • Founder of the working group for Lipidology, Vascular biology and Research “WGLVR”, division of the Egyptian Society of Cardiology
  • Founding member of the insurance committee for cardiology in Menofia governorate
  • Secretary EgSC 2006-2010
  • Chairman of the Egyptian Board for Accreditation in Cardiology (EGBAC) since November 2007
  • Fellowship of the European society of cardiology ESC
  • Chairman of the 38th annual international conference of the EgSC Feb. 2011
  • Faculty member Euro PCI
  • Faculty member TCT 2010( moderator and discussant)

 

Research:

  • Publishing and supervising MS and MD thesis and papers in different cardiovascular subjects.
  • Principle investigator and chairman of the executive committee of the “Egyptian Lipid and Risk Factors Project” current multi-center observational study of the pattern of risk factor profile of Egyptian patients with ACS: a prospective 3year study.
  • Principle investigator: Protocol Title: “A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome (ACS) Subjects with Unstable Angina/Non-ST-Elevation Myocardial Infarction (UA/NSTEMI) Who are Medically Managed – The TRILOGY ACS Study”. Protocol Number: H7T-MC-TABY(b). Sponsor: Eli-Lilly
  • Principle investigator of ATLAS ACS 2 TIMI 51 / RIVAROXACS3001 Study RIVAROXACS-3001, sponsored by Johnson and Johnson
  • Principle investigator EXAMINE – ProtocolSYR-322_402 Protocol Title: “A Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment with an Alogliptin, in Addition to Standard of Care, in Subjects with Type 2 Diabetes and Acute Coronary Syndrome
  • Centralized Pan-Middle East Survey on the Under-Treatment of Hypercholesterolemia: Results from the CEPHEUS Study in Egypt Cardiology and Therapy. November 2014, Date: 18 Nov 2014; A. Reda, A. A. Abdel-Rehim, A. Etman, O. S. A. Afifi
  • ESC heart failure 8, July, 2015 :Clinical characteristics and management of hospitalized and ambulatory patients with heart failure–results from ESC heart failure long-term registry–Egyptian cohort

Article first published online: 8 JUL 2015. DOI: 10.1002/ehf2.12046

Contacts:

Ashraf Reda MD,FESC

Mobile: 00201002122902

Fax: 002-02-23937967

E-mail: ashrafreda5555@gmail.com

ashraf.reda@eavasociety.org

Web site: www.cardio-.org

Office: !-  127 Mohd. Fareed St. Bab-Ellouk- Cairo-Egypt

2-  1 Gamal abdelnaser St Shebin Elkom-Egypt

Office: College of Medicine, Menofia University, Shebin Elkom- Menofia- Egypt